Sign in

CIK 0001874252

  • Emerging growth company

Quantum Cyber N.V.

Sign in to watch
Ticker
QUCY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
Operating
Phone
+49 61315542860
Business address
ROBERT KOCH STRASSE 50, MAINZ, Germany
Former names
MAINZ BIOMED N.V., Mainz Biomed B.V.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-11 Caragol William J Chief Financial Officer Grant or award · Stock Option (Right to Buy) +212,500 212,500
2026-08-05 Lazar David E. Chief Executive Officer Conversion +9,000,000 $9.00 $81.0M 9,000,000
2026-08-05 Lazar David E. Chief Executive Officer Conversion +9,000,000 $9.00 $81.0M 18,000,000
2026-08-05 Lazar David E. Chief Executive Officer Conversion +9,000,000 $9.00 $81.0M 27,000,000
2026-08-05 Lazar David E. Chief Executive Officer Conversion +28,057,500 $225.00 $6.3B 55,057,500
2026-08-05 Lazar David E. Chief Executive Officer Conversion · Series A Preferred Shares −1,000,000 0
2026-08-05 Lazar David E. Chief Executive Officer Conversion · Series B Preferred Shares −1,000,000 0
2026-08-05 Lazar David E. Chief Executive Officer Conversion · Series C Preferred Shares −1,000,000 0
2026-08-05 Lazar David E. Chief Executive Officer Conversion · Series D Preferred Shares −124,700 875,300
2026-07-31 Ben-Tzvi Avraham Director Grant or award +112,259 251,400
2026-07-31 O'Rourke Peter Director Grant or award · Stock Option (Right to Buy) +190,840 190,840
2026-07-31 NATAN DAVID Director Grant or award · Stock Option (Right to Buy) +190,840 190,840
2026-07-31 Caragol William J Chief Financial Officer Grant or award · Stock Option (Right to Buy) +212,500 212,500
2026-07-31 Buffalino Louis R. Director Grant or award · Stock Option (Right to Buy) +425,000 425,000
2026-07-22 O'Rourke Peter Director Grant or award · Stock Option (Right to Buy) +191,860 191,860
2026-07-22 NATAN DAVID Director Grant or award · Stock Option (Right to Buy) +191,860 191,860
2026-07-22 Caragol William J Chief Financial Officer Grant or award · Stock Option (Right to Buy) +212,500 212,500
2026-07-22 Buffalino Louis R. Director Grant or award · Stock Option (Right to Buy) +425,000 425,000
2026-07-22 Ben-Tzvi Avraham Director Grant or award +112,859 252,000
2026-07-06 O'Rourke Peter Director Grant or award · Stock Option (Right to Buy) +112,859 112,859

Page 1 of 2 · 33 trades